rofecoxib and warfarin
rofecoxib has been researched along with warfarin in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Davis, JV; Linder, JD; Mönkemüller, KE; Wilcox, CM | 1 |
| Bugianesi, KJ; De Smet, M; Dieck, J; Ebel, DL; Gertz, BJ; Haesen, R; Hunt, TL; Keymeulen, B; Ko, A; Larson, PJ; Lens, S; Lins, R; Porras, AG; Schwartz, JI; Verbesselt, R | 1 |
| Josefson, D | 1 |
| Killen, JP | 1 |
| Egan, M; Morreale, AP; Plowman, BK; Schaefer, MG | 1 |
Trials
2 trial(s) available for rofecoxib and warfarin
| Article | Year |
|---|---|
The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Topics: Adult; Anticoagulants; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Humans; Lactones; Male; Prothrombin Time; Sulfones; Warfarin | 2000 |
Interaction of rofecoxib and celecoxib with warfarin.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Synergism; Female; Humans; International Normalized Ratio; Isoenzymes; Lactones; Male; Membrane Proteins; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Warfarin | 2003 |
Other Studies
6 other study(ies) available for rofecoxib and warfarin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthritis; Atrial Fibrillation; Bicarbonates; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gastric Mucosa; Gastrointestinal Hemorrhage; Hip Joint; Humans; Hypoprothrombinemias; Incidence; Intestinal Mucosa; Isoenzymes; Lactones; Male; Membrane Proteins; Mucus; Peroxidases; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Warfarin | 2000 |
FDA warns Merck over its promotion of rofecoxib.
Topics: Anticoagulants; Cyclooxygenase Inhibitors; Drug and Narcotic Control; Drug Industry; Drug Interactions; Lactones; Stroke; Sulfones; United States; United States Food and Drug Administration; Warfarin | 2001 |
The coxibs, selective inhibitors of cyclooxygenase-2.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Humans; International Normalized Ratio; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Warfarin | 2001 |